Veradermics MANE
NYSE MANE
$117.54 +2.54 (+2.21%)
As of: Sep 29, 2026 · 3:59 PM EDT

Veradermics (MANE) Research & Development (2025 - 2026)

Updated

Veradermics (MANE) recorded Research & Development of $18.61 million in Q2 2026, up 29.9% from $14.33 million a year earlier but down 11.1% from the prior quarter.

Analysis

Veradermics (MANE) Research & Development (2025 - 2026) Analysis & Trends

On a TTM basis, Veradermics' Research & Development came in at $65.31 million as of Jun 30, 2026; for FY2025, it came in at $62.07 million, up 166.6% from FY2024.

  • Across earlier years, Research & Development came in at $23.28 million in FY2024.
  • Quarterly Research & Development has ranged from $11.45 million in Q1 2025 to $20.93 million in Q1 2026 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Veradermics 4.80 Bn 4.80 Bn - 18.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.61 Mn
Mar 31, 2026 20.93 Mn
Jun 30, 2025 14.33 Mn
Mar 31, 2025 11.45 Mn
API Access

Veradermics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=MANE&period=max&api_key=YOUR_API_KEY